BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10092820)

  • 1. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes.
    Ottonello L; Tortolina G; Amelotti M; Dallegri F
    J Immunol; 1999 Mar; 162(6):3601-6. PubMed ID: 10092820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation.
    Dupont PJ; Warrens AN
    Immunology; 2007 Jan; 120(1):133-9. PubMed ID: 17233740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
    Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD
    Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic activity of soluble Fas ligand against phagocytes.
    Seino K; Iwabuchi K; Kayagaki N; Miyata R; Nagaoka I; Matsuzawa A; Fukao K; Yagita H; Okumura K
    J Immunol; 1998 Nov; 161(9):4484-8. PubMed ID: 9794371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.
    Fujino M; Li XK; Suda T; Hashimoto M; Okabe K; Yaginuma H; Mikoshiba K; Guo L; Okuyama T; Enosawa S; Amemiya H; Amano T; Suzuki S
    Xenotransplantation; 2001 May; 8(2):115-24. PubMed ID: 11328582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R; Seifert M; Asadullah K; Volk HD
    J Immunol; 1999 Jun; 162(12):7140-7. PubMed ID: 10358159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.
    Tada Y; O-Wang J; Seimiya M; Takiguchi Y; Tatsumi K; Kuriyama T; Tagawa M
    Anticancer Res; 2002; 22(2A):831-6. PubMed ID: 12014659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes.
    Brown SB; Savill J
    J Immunol; 1999 Jan; 162(1):480-5. PubMed ID: 9886423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity.
    Shimizu M; Fontana A; Takeda Y; Yoshimoto T; Tsubura A; Matsuzawa A
    Cell Immunol; 2001 Jan; 207(1):41-8. PubMed ID: 11161452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M; Fontana A; Takeda Y; Yagita H; Yoshimoto T; Matsuzawa A
    J Immunol; 1999 Jun; 162(12):7350-7. PubMed ID: 10358186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune privilege or inflammation? The paradoxical effects of Fas ligand.
    O'Connell J
    Arch Immunol Ther Exp (Warsz); 2000; 48(2):73-9. PubMed ID: 10807046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Fas, FasL, and soluble Fas mRNA in endomyocardial biopsies of human cardiac allografts.
    PĂ©rez EC; Shulzhenko N; Morgun A; Diniz RV; Almeida DR; Musatti CC; Gerbase-DeLima M
    Hum Immunol; 2006; 67(1-2):22-6. PubMed ID: 16698421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC
    Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis of bovine ovarian surface epithelial cells by Fas antigen/Fas ligand signaling.
    Margalit KA; Cowan RG; Harman RM; Quirk SM
    Reproduction; 2005 Nov; 130(5):751-8. PubMed ID: 16264104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-cleavable mutant of Fas ligand does not prevent neutrophilic destruction of islet transplants.
    Kang SM; Braat D; Schneider DB; O'Rourke RW; Lin Z; Ascher NL; Dichek DA; Baekkeskov S; Stock PG
    Transplantation; 2000 May; 69(9):1813-7. PubMed ID: 10830216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
    Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
    J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
    Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system.
    Caricchio R; Kovalenko D; Kaufmann WK; Cohen PL
    Clin Immunol; 1999 Oct; 93(1):65-74. PubMed ID: 10497012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients.
    Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K
    Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.